Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study

ConclusionThis post-marketing data confirms the short-term safety, tolerability and effectiveness of DMF, supporting its use as an early treatment in MS.

http://link.springer.com/10.1007/s40263-018-0543-3

Source: CNS Drugs - July 18, 2018 Category: Neurology Source Type: research